Article Information
History
- May 1, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Iolanda Valentina Popa, MD, PhD1,
- Mircea Diculescu, MD, PhD2,
- Cătălina Mihai, MD, PhD3,*,
- Cristina Cijevschi-Prelipcean, MD, PhD4 and
- Alexandru Burlacu, MD, PhD5
- 1Institute of Gastroenterology and Hepatology, Iasi, Romania, and ‘Grigore T. Popa’ University of Medicine, Iasi, Romania; iolivp{at}gmail.com
- 2Department of Gastroenterology, Fundeni Clinical Institute, Bucharest, Romania, and ‘Carol Davila’ University of Medicine and Pharmacy, Bucharest, Romania; mmdiculescu{at}yahoo.com
- 3Institute of Gastroenterology and Hepatology, Iasi, Romania, and‘Grigore T. Popa’ University of Medicine, Iasi, Romania; catalinamihai{at}yahoo.com
- 4Institute of Gastroenterology and Hepatology, Iasi, Romania, and ‘Grigore T. Popa’ University of Medicine, Iasi, Romania; cristinacijevschi{at}yahoo.com
- 5Head of Department of Interventional Cardiology - Cardiovascular Diseases Institute, and ‘Grigore T. Popa’ University of Medicine, Iasi, Romania; alexandru.burlacu{at}umfiasi.ro; alburlacu{at}yahoo.com
- ↵*Correspondence
: Cătălina Mihai MD, PhD, Institute of Gastroenterology and Hepatology, Bd, Independentei No 1, Iasi, 700111, ROMANIA, Phone: + 40745258797, email: catalinamihai{at}yahoo.com, https://orcid.org/0000-0001-9375-9224
Posted May 01, 2020.
COVID-19 and Inflammatory Bowel Diseases: risk assessment, shared molecular pathways and therapeutic challenges
